UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
|
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 7)
|
| CEPTON, INC. |
(Name of Issuer)
|
| Common Stock, par value $0.00001 per share |
(Title of Class of Securities)
|
| 15673X 200 |
(CUSIP Number)
|
|
Satoshi Kabashima
KOITO MANUFACTURING CO., LTD.
Sumitomo Fudosan Osaki Twin Bldg. East
5-1-18, Kitashinagawa, Shinagawa-ku
Tokyo 141-0001
Japan
Telephone: +81-3-3447-5142 |
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
|
| July 29, 2024 |
(Date of Event which Requires Filing of this Statement)
|
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-l(f) or 240.13d-l(g), check the following box. ☐
|
| Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. |
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
| The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). |
| CUSIP No. 15673X 200 |
| 1. |
Names of Reporting Persons.
KOITO MANUFACTURING CO., LTD. |
| 2. |
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ☐
(b) ☐ |
| 3. |
SEC Use Only
|
| 4. |
Source of Funds (See Instructions)
WC
|
| 5. |
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) |
☐
|
| 6. |
Citizenship or Place of Organization
Japan
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH |
7. |
Sole Voting Power
6,075,057 shares of Common Stock1
|
| 8. |
Shared Voting Power
6,207,0862
|
| 9. |
Sole Dispositive Power
6,075,057 shares of Common Stock1
|
| 10. |
Shared Dispositive Power
6,207,0862
|
| 11. |
Aggregate Amount Beneficially Owned by Each Reporting Person
12,282,143 shares of Common Stock1, 2
|
| 12. |
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) |
☐
|
| 13. |
Percent of Class Represented by Amount in Row (11)
50.9%3
|
| 14. |
Type of Reporting Person (See Instructions)
CO
|
1 Includes 4,112,583 shares of Common Stock (as
defined in Item 1 below) to which the 100,000 shares of non-voting Series A Preferred Stock (as defined in Item 4 below) owned by the
Reporting Person are convertible (taking into account dividends accrued but unpaid as of June 30, 2024), subject to adjustment.
2 Beneficial ownership of 6,207,086 shares of
Common Stock is being reported hereunder solely because the Reporting Person may be deemed to have beneficial ownership of such securities
as a result of the Voting Support Agreements (as defined in Item 4 below) entered into with beneficial owners of such securities as described
herein. Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission by the Reporting Person
that it is the beneficial owner of any such securities referred to herein for purposes of Section 13(d) of the Securities Exchange Act
of 1934, as amended, or for any other purpose, and such beneficial ownership is expressly disclaimed.
3 Based on 16,043,207 shares of Common Stock outstanding
as of June 30, 2024, based on information provided to the Reporting Person by Cepton, Inc.
Item 1. Security and Issuer
This statement constitutes Amendment
Number 7 to the Schedule 13D (this “Statement”) relating to shares of common stock, par value $0.00001 per share (“Common
Stock”), of Cepton, Inc., a Delaware corporation, whose principal executive offices are located at 399 West Trimble Road, San
Jose, California 95131, and whose designated business telephone number is (408) 459-7579 (the “Issuer”), and hereby
amends the Schedule 13D filed with the Securities and Exchange Commission (the “Commission”) on February 18, 2022 (the
“Initial Statement”) on behalf of the Reporting Person to furnish the additional information set forth herein. Information
given in response to each item shall be deemed incorporated by reference in all other items as applicable.
Item 3. Source and Amount
of Funds or Other Consideration
Item 3 of the Initial Statement is
hereby amended by adding the following paragraph:
The description of the Transaction
set forth and defined in Item 4 of this Statement is incorporated by reference in its entirety into this Item 3. It is anticipated that
funding for the cash consideration payable pursuant to the Merger Agreement (as defined below) will be obtained through Reporting Person’s
existing resources including cash on hand.
Item 4. Purpose of Transaction
Item 4 is hereby supplemented by adding
the following paragraphs:
Merger Agreement
Agreement and Plan of Merger
On July 29, 2024, the Issuer entered
into an Agreement and Plan of Merger (the “Merger Agreement”) with the Reporting Person and Project Camaro Merger Sub,
Inc., a Delaware corporation and an indirectly wholly owned subsidiary of the Reporting Person (“Merger Sub”).
The Merger Agreement and the other
transactions contemplated thereby (the “Transaction”) were approved by the Issuer’s Board of Directors (the “Issuer
Board”) based upon the unanimous recommendation of a special committee thereof consisting only of independent and disinterested
directors (the “Special Committee”). Subject to the terms of the Merger Agreement, the Issuer Board resolved to recommend
that the Issuer’s stockholders vote in favor of adoption of the Merger Agreement and approval of the Transaction.
The Merger Agreement provides that,
among other things and on the terms and subject to the conditions set forth in the Merger Agreement, (i) Merger Sub shall be merged with
and into the Issuer (the “Merger”), with the Issuer continuing as the surviving corporation (the “Surviving
Corporation”) and an indirect subsidiary of the Reporting Person; (ii) at the effective time of the Merger (the “Effective
Time”) each share of Common Stock issued and outstanding immediately before the Effective Time (other than (a) shares of
Common Stock held by any subsidiary of the Issuer immediately prior to the Effective Time; (b) shares of Common Stock held by the
Reporting Person or any of its subsidiaries or owned by the Issuer as treasury stock, in each case, immediately prior to the Effective
Time; and (c) shares of Common Stock that are issued and outstanding immediately prior to the Effective Time and for which the holder
thereof is entitled to demand and properly demands the appraisal of such shares in accordance with, and complied in all respects with,
Section 262 of the General Corporation Law of the State of Delaware) shall be converted automatically into the right to receive $3.17
per share without interest (the “Merger Consideration”); and (iii) each share of capital stock of Merger Sub issued
and outstanding immediately prior to the Effective Time shall be converted into and become one (1) fully paid and non-assessable share
of common stock, par value $0.00001 per share, of the Surviving Corporation.
Each share of Series A Convertible
Preferred Stock of the Issuer, par value $0.00001 per share (“Series A Preferred Stock”), issued and outstanding immediately
prior to the Effective Time shall remain outstanding and shall not be cancelled. The Issuer’s warrants to acquire up to 862,500
shares of Common Stock issued and outstanding on the date of the Merger Agreement (the “Public Warrants”) and warrants
to acquire up to 517,000 shares of Common Stock (the “Private Warrants” and, together with the Public Warrants, the
“Warrants”) that are outstanding and unexercised as of immediately prior to the Effective Time shall be treated in
accordance with the terms and conditions of the Warrant Agreement, dated as of January 29, 2021 by and between the Issuer and Continental
Stock Transfer & Trust Company. The Issuer’s earnout shares (“Earnout Shares”) shall be treated in accordance
with the terms and conditions of the Business Combination Agreement, dated as of August 4, 2021, by and among the Issuer, GCAC Merger
Sub Inc. and Cepton Technologies, Inc., as amended, pursuant to which, at the Effective Time, the Earnout Shares shall (i) be deemed unearned
as the Merger Consideration does not exceed
the share price milestone thresholds
applicable to the Earnout Shares and (ii) be cancelled. If the Merger is consummated, shares of Common Stock and Public Warrants will
be delisted from the Nasdaq Stock Market and deregistered under the Securities Exchange Act of 1934.
Treatment of Company Equity
Awards
The Merger Agreement provides that
at or immediately prior to the Effective Time:
| (a) | each compensatory option to purchase shares of Common Stock (an “Issuer Option”) that is outstanding immediately
prior to the Effective Time, whether or not vested or exercisable, shall be cancelled, and the holder of any such option shall be entitled
to receive, at or promptly after the Effective Time, an amount in cash, less any withholding taxes, determined by multiplying (a) the
excess, if any, of the per share Merger Consideration over the applicable exercise price per share of the Issuer Option by (b) the number
of shares of Common Stock subject to such Issuer Option immediately prior to the Effective Time; |
| (b) | each service-based restricted stock unit or deferred stock unit of the Issuer (“Issuer RSU”) that is outstanding
immediately prior to the Effective Time, whether or not vested, shall be canceled, and the holder of any such Issuer RSU will be entitled
to receive (without interest), at or promptly after the Effective Time, for each such Issuer RSU an amount in cash, less any withholding
taxes, determined by multiplying the per share Merger Consideration by the number of shares of Common Stock underlying such Issuer RSU
immediately prior to the Effective Time; provided, that as to any such Issuer RSU that is not vested as of the Effective Time, the Merger
Consideration for such unvested Issuer RSU will remain subject to the vesting conditions that applied to such Issuer RSU immediately prior
to the Effective Time (including any provisions for accelerated vesting of such Issuer RSU in connection with a termination of the holder’s
employment) and shall be payable only if and to the extent such vesting conditions are satisfied; and |
| (c) | each award of performance-based restricted stock units of the Issuer (“Issuer PSU”) that is outstanding immediately
prior to the Effective Time shall vest as to the number of Issuer PSUs determined in accordance with the applicable award agreement and
shall be canceled and converted into the right to receive (without interest), at or promptly after the Effective Time, an amount in cash
(without interest) determined by multiplying the per share Merger Consideration by the number of shares of Common Stock underlying such
vested Issuer PSUs, less any withholding taxes. Any Issuer PSU that is not vested as of immediately prior to the Effective Time shall
be canceled at the Effective Time without payment of any consideration therefor. |
Conditions to the Merger
The consummation of the Transaction
is subject to the fulfillment or waiver of certain customary mutual conditions, including the receipt of the requisite stockholder approval
at a meeting of the Issuer’s stockholders.
The consummation of the Transaction
is also subject to the fulfillment or waiver of certain unilateral conditions, including (i) the other party’s representations and
warranties being true and correct (subject to certain customary materiality exceptions), (ii) the other party’s fundamental representations
and warranties being true and correct in all material respects and (iii) the other party having performed and complied in all material
respects with its covenants, obligations and conditions of the Merger Agreement. The obligation of the Reporting Person to consummate
the Merger is additionally conditioned upon the absence of a material adverse effect on the Issuer that is continuing, and having obtained
approval from CFIUS.
Solicitation and Alternative
Proposals
From and after the date of the Merger
Agreement, the Issuer has agreed that it and its subsidiaries and their respective representatives will not solicit, initiate, knowingly
facilitate or knowingly encourage any inquiry, indication of interest, offer or proposal relating to an Acquisition Transaction (as defined
in the Merger Agreement) or enter into any agreement for an Acquisition Transaction or any agreement requiring the Issuer to abandon,
terminate or fail to consummate the Transaction.
The Issuer may, however, prior to obtaining
approval of the Issuer’s stockholders, respond to, engage in discussions with and provide information regarding the Issuer to a
third party which has made a proposal, if the Issuer Board (acting on the recommendation of the Special Committee) determines in good
faith, after consultation with outside counsel and its financial advisor, that such proposal constitutes, or would reasonably be expected
to lead to a Superior Proposal (as defined in the Merger Agreement).
Prior to obtaining the requisite stockholder
approval, the Issuer Board may, in certain circumstances, effect a Company Board Recommendation Change (as defined in the Merger Agreement)
and/or terminate the Merger Agreement, subject to complying with specified notice requirements to the Reporting Person and other conditions
set forth in the Merger Agreement, including paying a termination fee to the Reporting Person in specified circumstances, as described
below.
Termination and Fees
The Merger Agreement provides for the
termination of the agreement under certain circumstances, including among others (i) subject to certain limitations, if the consummation
of the Merger has not occurred by April 29, 2025 (subject to an extension, at the election of either the Reporting Person or the Issuer,
to July 29, 2025 if on such date all of the conditions to the closing of the Merger, except those relating to the approval of CFIUS, have
been satisfied or waived) (the “End Date”), (ii) by either party if the Issuer fails to obtain the requisite stockholder
approval at a meeting of the Issuer’s stockholders, (iii) by the Reporting Person at any time prior to the Issuer’s receipt
of the requisite stockholder approval if the Issuer Board has effected a Company Board Recommendation Change, (iv) by either party for
breaches by the other party of certain representations and warranties, and (v) by the Issuer at any time prior to the Issuer’s receipt
of its requisite stockholder approval, if the Issuer Board (acting on the recommendation of the Special Committee) determines to terminate
the Merger Agreement with respect to a Superior Proposal.
The Issuer will be required to pay
a termination fee to the Reporting Person equal to $1,250,000 if the Merger Agreement is
terminated in certain circumstances, including, if (i) the Reporting Person terminates the Merger Agreement following a Company Board
Recommendation Change, (ii) the Issuer terminates the Merger Agreement with respect to a Superior Proposal, and (iii) either party terminates
the Merger Agreement following the Issuer’s failure to obtain the requisite stockholder approval at a meeting of the Issuer’s
stockholders and (a) prior to such termination an Acquisition Proposal (as defined in the Merger Agreement) had been publicly disclosed
and not withdrawn or otherwise made to the Issuer Board or the Special Committee and (b) within twelve months following the date of such
termination the Issuer consummates any Acquisition Proposal (it being understood that for all purposes of the Issuer’s payment of
a termination fee, references in the definition of “Acquisition Proposal” to 20% are to be deemed references to 50%).
The Reporting Person will be required
to pay a reverse termination fee to the Issuer equal to $5,000,000 if the Merger Agreement is terminated in certain circumstances, including,
if the Merger Agreement is terminated by (i) either party if the Merger is not consummated by the End Date, the CFIUS Approval (as defined
in the Merger Agreement) was not obtained and at the time of such termination each of the other conditions to the closing of the Merger
have been satisfied, (ii) either party to the extent any governmental entity with competent jurisdiction has issued or enacted a final
and nonappealable legal restraint that prohibits, makes illegal or enjoins the consummation of the Merger to the extent relating to the
CFIUS Approval, and (iii) the Issuer in the event the Reporting Person breaches or fails to perform in any material respect any of its
covenants relating to the CFIUS Approval.
The Merger Agreement also provides
that, in certain circumstances, either party may seek to compel the other party to specifically perform its obligations under the Merger
Agreement.
Other Terms of the Merger Agreement
The Issuer has made customary representations,
warranties and covenants in the Merger Agreement, including, among others, covenants to use reasonable best efforts to conduct its business
in the ordinary course during the period between the date of the Merger Agreement and the consummation of the Merger. The parties have
agreed to use reasonable best efforts to take all actions necessary to consummate the Merger, including cooperating to obtain the regulatory
approvals necessary to consummate the Merger.
The foregoing description of the Merger
Agreement is not complete, and is qualified in its entirety by reference to the Merger Agreement, which is incorporated by reference to
Exhibit 2.1 to the Issuer’s Current Report on Form 8-K filed with the Commission on July 29, 2024.
The Merger Agreement has been included
to provide investors with information regarding its terms. It is not intended to provide any other factual information about the Issuer,
the Reporting Person, Merger Sub or their respective affiliates. The representations, warranties and covenants contained in the Merger
Agreement were made only for the purposes of the Merger Agreement as of the specific dates therein, were solely for the benefit of the
parties to the Merger Agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential
disclosures made for the purposes of allocating contractual risk among the parties to the Merger Agreement instead of establishing these
matters as facts, and may be subject to standards of
materiality applicable to the contracting
parties that differ from those applicable to investors. Investors should not rely on the representations, warranties and covenants or
any descriptions thereof as characterizations of the actual state of facts or condition of the parties thereto or any of their respective
subsidiaries or affiliates. Moreover, information concerning the subject matter of representations and warranties may change after the
date of the Merger Agreement, which subsequent information may or may not be reflected in the Issuer’s public disclosures. The Merger
Agreement should not be read alone, but should instead be read in conjunction with the other information regarding the Issuer, the Reporting
Person and Merger Sub and the transactions contemplated by the Merger Agreement that will be contained in or attached as an annex to the
Proxy Statement that the Issuer will file in connection with the transaction contemplated by the Merger Agreement, as well as in the other
filings that the Issuer will make with the Commission.
Voting Support Agreements
Concurrent with the execution of the
Merger Agreement, the Reporting Person and each of Dr. Jun Pei, Dr. Jun Ye and Dr. Mark McCord (the “Supporting Stockholders”)
entered into voting support agreements (the “Voting Support Agreements”), pursuant to which, among other things, each
of the Supporting Stockholders agreed, subject to the terms thereof, to vote or cause to be voted, all of the shares of Common Stock beneficially
owned by such Supporting Stockholders in favor of the adoption of the Merger Agreement. The aggregate number of shares of Common Stock
beneficially owned by the Supporting Stockholders and required to be voted or cause to be voted in favor of the adoption of the Merger
Agreement pursuant to the Voting Support Agreements represents approximately 38.7% of the outstanding shares of Common Stock, and along
with the shares of Common Stock beneficially owned by the Reporting Person (excluding the Common Stock to which the shares of Series A
Preferred Stock held by the Reporting Person are convertible), approximately 50.9% of the outstanding shares of Common Stock. In the event
that the Issuer Board effects a Recommendation Change, then the aggregate number of shares of Common Stock beneficially owned by the Supporting
Stockholders and required to be voted or caused to be voted in favor of the adoption of the Merger Agreement pursuant to the Voting Support
Agreements, along with the shares of Common Stock beneficially owned by the Reporting Person (including the Common Stock to which the
shares of Series A Preferred Stock held by the Reporting Person are convertible), would be reduced to represent 35% of the outstanding
shares of Common Stock.
The foregoing description of the Voting
Support Agreements is not complete and is qualified in its entirety by reference to the form of Voting Support Agreement, which is incorporated
by reference to Exhibit 10.1 to the Issuer’s Current Report on Form 8-K filed with the Commission on July 29, 2024.
Rollover Agreement
Concurrent with the execution of
the Merger Agreement, the Reporting Person, Project Camaro Holdings, LLC, a Delaware limited liability company and wholly owned subsidiary
of the Reporting Person (“Holdco”), Dr. Jun Pei, Dr. Mark McCord and Mr. Yupeng Cui (Dr. Jun Pei, Dr. Mark McCord and
Mr. Yupeng Cui together, the “Rollover Participants”) entered into a rollover agreement (the “Rollover Agreement”),
pursuant to which, immediately prior to the Effective Time, Dr. Jun Pei, Dr. Mark McCord and Mr. Yupeng Cui will contribute 1,291,810,
515,886 and 476,549 shares of Common Stock (the “Rollover Shares”), respectively, and the Reporting Person will separately
contribute its 1,962,474 shares of Common Stock and 100,000 shares of Series A Preferred Stock as contemplated therein, to Holdco in exchange
for certain equity interests in Holdco. Pursuant to the Rollover Agreement, the Rollover Participants agreed to certain restrictive covenants,
including restrictions on competition and solicitation. The Rollover Agreement also contemplates that at the closing, the Rollover Participants,
the Reporting Person and Holdco will enter into an Amended and Restated Limited Liability Company Agreement of Holdco, which provides
for scheduled repurchases of the equity interests issued to the Rollover Participants at a purchase price determined by multiplying the
number of Rollover Shares by the Merger Consideration, plus an applicable rate of interest, subject to acceleration or reduction in certain
circumstances.
The foregoing description of the Rollover
Agreement is not complete, and is qualified in its entirety by reference to the Rollover Agreement, a copy of which is attached to this
Statement and incorporated by reference herein.
Item 5. Interest in Securities of the Issuer
Items
5(a) and (b) of the Initial Statement are hereby amended and replaced with the following:
| (a) | The Reporting Person directly owns 1,962,474 shares of Common Stock and 100,000 shares of Series A Preferred Stock convertible into
4,112,583 shares of Common Stock (taking into account dividends accrued but unpaid as of June 30, 2024), subject to adjustment, representing
approximately 30.14% of the 20,155,790 shares of Common Stock issued and outstanding (calculated as the sum of (i) |
16,043,207 shares of Common Stock outstanding
as of June 30, 2024, based on information provided to the Reporting Person by the Issuer and (ii) 4,112,583 shares of Common Stock into
which the 100,000 shares of Series A Preferred Stock owned by the Reporting Person are convertible (taking into account dividends accrued
but unpaid as of June 30, 2024)).
| (b) | The Reporting Person has the sole power to vote and dispose of 1,962,474 shares of Common Stock and 4,112,583 shares of Common Stock
issuable upon the conversion of 100,000 shares of Series A Preferred Stock (taking into account dividends accrued but unpaid as of June
30, 2024), subject to adjustment. As a result of the Voting Support Agreements, the Reporting Person could be deemed to have shared power
to vote and dispose of 6,207,086 shares of Common Stock that are subject to the Voting Support Agreements, of which Dr. Jun Pei, the Issuer’s
President and Chief Executive Officer and Chairman of the Board, has the power to vote and dispose of 2,583,620 shares of Common Stock
(including 2,445,426 shares of Common Stock owned by the Pei 2000 Trust of which Dr. Pei is a trustee), Dr. Jun Ye, a member of the Board,
has the power to vote and dispose of 2,591,695 shares of Common Stock (including 244,923, 244,923 and 20,000 shares of Common Stock owned
by the Lynnelle Lin Ye Irrevocable Trust, the Brion Qi Ye Irrevocable Trust and the Ye-Wang Family Trust, respectively, each trust of
which Dr. Ye is a trustee), and Dr. Mark McCord, the chair of the Issuer’s Technology Advisory Board, has the power to vote and
dispose of 1,031,771 shares of Common Stock (including 1,030,924 shares of Common Stock owned by the McCord Trust, of which Dr. McCord
is a trustee). |
Item 6. Contracts, Arrangements, Understandings
or Relationships With Respect to Securities of the Issuer
Item
6 of the Initial Statement is hereby amended by incorporating by reference in its entirety the description of the Merger Agreement, the
Voting Support Agreements and the Rollover Agreement set forth in Item 4 above.
Item 7. Material to be Filed as Exhibits
|
Exhibit
No. |
|
Description |
| |
|
|
| 99.10 |
|
Agreement and Plan of Merger, by and among the Issuer, the Reporting Person and Merger Sub, dated July 29, 2024 (incorporated by reference to Exhibit 2.1 to the Issuer’s Current Report on Form 8-K filed with the Commission on July 29, 2024). |
| 99.11 |
|
Form of Voting Support Agreement (incorporated by reference to Exhibit 10.1 to the Issuer’s Current Report on Form 8-K filed with the Commission on July 29, 2024) |
| 99.12 |
|
Rollover Agreement, by and among the Reporting Person, Holdco and the Rollover Participants, dated July 29, 2024. |
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: July 29, 2024
| |
KOITO MANUFACTURING CO., LTD. |
| |
|
|
| |
By: |
/s/ Takahito Otake
|
| |
Name: |
Takahito Otake |
| |
Title: |
Senior Managing Corporate Officer |
Exhibit 99.12
ROLLOVER AGREEMENT
This ROLLOVER AGREEMENT (this “Agreement”),
dated as of July 29, 2024 is entered into by and among KOITO MANUFACTURING CO., LTD., a corporation organized under the laws of Japan
(“Buyer”), Project Camaro Holdings, LLC, a Delaware limited liability company and wholly owned subsidiary of Buyer
(“Holdco”), and each holder of shares of Company Common Stock of Cepton, Inc., a Delaware corporation (the “Company”)
that is or may become a party to this Agreement by virtue of executing a counterpart or joinder hereto (each, a “Covered Person”).
Any capitalized term that is used, but not defined, herein shall have the meaning ascribed to such term in the Merger Agreement (as defined
below).
WHEREAS, Buyer, Project Camaro Merger Sub, Inc.,
a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of Holdco and the Company have, prior to or concurrently
with the execution and delivery herewith, entered or will enter into an Agreement and Plan of Merger dated as of the date hereof (as amended
or modified from time to time, the “Merger Agreement”), providing for, among other things, the merger of Merger Sub
with and into the Company such that the Company will become a wholly owned subsidiary of Holdco (collectively, the “Merger”);
WHEREAS, prior to the Closing, Buyer will contribute
to Holdco in exchange for newly issued units of Holdco (the “Holdco Securities”) the following: (i) all shares of Company
Common Stock held by Buyer, valuing each such share of Company Common Stock at the amount of the Merger Consideration per share to be
paid in cash pursuant to the Merger in respect of a share of Company Common Stock (such valuation, the “Agreed Per Share Value”),
(ii) all shares of Series A Preferred Stock held by Buyer, valuing each such share of Series A Preferred Stock at the liquidation preference
for such share of Series A Preferred Stock at the time of the contribution and (iii) an amount of cash necessary for Merger Sub or Surviving
Corporation to pay the Merger Consideration and any other consideration (including, but not limited to, amounts to be paid in respect
of Company Options or Company RSUs) or other costs or expenses required to be paid by Merger Sub or Surviving Corporation in connection
with the Transaction (which amount, upon such contribution by Buyer to Holdco, will be immediately contributed from Holdco to Merger Sub
in exchange for newly issues shares of Merger Sub); and
WHEREAS, as an inducement to Buyer’s and
Merger Sub’s willingness to enter into the Merger Agreement and the other Transaction Documents to which they are a party, each
Covered Person, and if applicable, his or her Spouse, has agreed to execute and deliver this Agreement.
NOW, THEREFORE, in consideration of the foregoing
and the representations, warranties, covenants and agreements contained herein, and for other good and valuable consideration (the receipt
and sufficiency of which is hereby acknowledged and agreed), each of the parties hereto, intending to be legally bound, hereby agree as
follows:
1.
Rollover Contribution; Subscription for New Holdco Securities.
(a)
Rollover Contribution. Each Covered Person agrees, severally and not jointly and solely with respect to itself, himself
or herself, that, effective as of immediately prior to the Effective Time, all of such Covered Person’s ownership of and title to
the number of shares of Company Common Stock set forth on such Covered Person’s signature page hereto ( the “Committed
Rollover Shares”), free and clear of all Liens and any other limitation or restriction (including any restriction on the right
to vote, sell or otherwise dispose of the Committed Rollover Shares), other than generally applicable transfer restrictions under the
Securities Act (as defined below), this Agreement or the Voting Support Agreements (if applicable to such Covered Person), shall be contributed
and assigned to Holdco. In exchange for the contribution of the Committed Rollover Shares by a Covered Person, Holdco hereby agrees to
issue to each such Covered Person, effective as of the Closing, a number of Holdco Securities equivalent to the shares of Company Common
Stock so contributed to Holdco, valuing each such share of Company Common Stock at the Agreed Per Share Value, with each such Holdco Security
free and clear of all Liens, other than restrictions under applicable securities laws and restrictions set forth in the LLC Agreement
(as defined below).
(b)
Continued Ownership of the Committed Rollover Shares. Each Covered Person agrees that, until the Closing, such Covered Person
shall continue to beneficially own a number of shares of Company Common Stock equal to the Committed Rollover Shares, and such Covered
Person shall not transfer or cause to be transferred any shares of Company Common Stock if such transfer would cause such Covered Person
to be unable to contribute the Committed Rollover Shares to Holdco in accordance with Section 1(a).
(c)
Joinders. Any holder of Company Common Stock (a “Holder”) who has not executed this Agreement as of the
date hereof may, with Buyer’s prior written consent, become a party to, and be bound by, this Agreement as a Covered Person by signing
and delivering to Buyer and Holdco a joinder in the form of Annex I hereto (a “Joinder Agreement”), and such
Holder shall be a Covered Person with respect to the Committed Rollover Shares set forth therein.
(d)
Tax Treatment. The parties hereto intend that, for U.S. federal income tax purposes, each contribution referred to in Section
1(a) shall be treated as a taxable transfer of the Committed Rollover Shares in exchange for a contingent installment obligation
governed by Treasury Regulations Section 15A.453-1(c) in a transaction governed by Section 1001 of the Code and subject to installment
sale reporting under Section 453 of the Code, and each party hereto will file all U.S. federal income tax returns in a manner consistent
with such treatment.
(e)
Withholding. Notwithstanding any other provision of this Agreement, Buyer, Holdco and their Affiliates shall be entitled
to deduct and withhold from any amount otherwise payable to any Covered Person pursuant to this Agreement or the LLC Agreement (as defined
below) such amounts as it is required to deduct and withhold with respect to the making of such payment under any provision of Law. To
the extent Buyer, Holdco or their Affiliates determine that any amounts payable to any Person pursuant to
or with respect to this Agreement, Buyer,
Holdco and their Affiliates shall use commercially reasonable efforts to provide such Person with three (3) Business Days prior notice
of the intent to withhold and shall cooperate with such Person to eliminate or otherwise reduce such withholding. Amounts so withheld
and paid over to the appropriate Governmental Authority shall be treated for all purposes of this Agreement as having been paid to the
applicable Covered Person in respect of which such deduction and withholding was made.
2.
LLC Agreement. Holdco and each Covered Person hereby agree, contemporaneously with the Closing, to enter into and become
bound by an amended and restated LLC Agreement, substantially as set forth on Annex II (the “LLC Agreement”).
Each Covered Person expressly acknowledges that the Holdco Securities acquired by such Covered Person pursuant to this Agreement shall
be subject to the restrictions on transfer and other terms and conditions of the LLC Agreement.
3.
Representations and Warranties. Each Covered Person (and, if applicable, his or her Spouse) hereby makes the representations
and warranties set forth on Annex III, severally and not jointly, to Holdco, as of the date hereof (or, in the case of any Covered
Person becomes a party hereto by delivering a Joinder Agreement as contemplated by Section 1(c), as of the date of such Joinder
Agreement) and as of the Closing, and as to itself, himself or herself only (and, if applicable, his or her Spouse), and Holdco hereby
makes the representations and warranties set forth on Annex IV, to each Covered Person, as of the date hereof and as of the Closing.
The representations and warranties made pursuant to this Section 3 shall survive the Closing.
4.
Restrictive Covenants.
(a)
Confidentiality. Each Covered Person acknowledges, on behalf of itself, himself or herself (and, if applicable, his or her
Spouse), that the success of the Company and its Subsidiaries after the Effective Time depends upon the continued preservation of the
confidentiality of information regarding the business, operations and affairs of the Buyer, the Company and/or their respective Subsidiaries
that has been maintained as confidential and is not publicly available (including trade secrets, confidential information and proprietary
materials, which may include the following categories of information and materials: methods, procedures, computer programs and architecture,
databases, customer information, lists and identities, employee lists and identities, pricing information, research, methodologies, contractual
forms, and other information, whether tangible or intangible, which is not publicly available generally) (collectively, the “Confidential
Information”) and has been accessed or possessed by such Covered Person and its, his or her Affiliates and that the preservation
of the confidentiality of such information is an essential premise of the transactions contemplated by the Merger Agreement, this Agreement
and the other Transaction Documents. Accordingly, each Covered Person hereby agrees not to disclose or use, and to use reasonable best
efforts to cause his, her or its Representatives not to disclose or use, any Confidential Information to any third party, both during
and after the Covered Person’s service as a service provider to Buyer, the Company and/or their respective Subsidiaries, except
(i) with respect to the Protected Rights (as defined below), (ii) to the extent that such Confidential
Information can be shown to have been in
the public domain through no fault of any Covered Person and (iii) to the extent that such Confidential Information is disclosed in connection
with the ordinary course performance of such Covered Person’s duties as a service provider to Holdco, Buyer, the Company and/or
their respective Subsidiaries (without violation of any agreements entered into in connection with such service relationship). In addition,
notwithstanding the foregoing and for the avoidance of doubt, such Covered Person may disclose such Confidential Information (w) on a
confidential basis to her, his or its tax and financial advisors for purposes of complying with such Covered Person’s tax obligations
or other reporting obligations under applicable Law arising out of this Agreement, the transactions contemplated hereby, the Merger Agreement
or the transactions contemplated thereby (provided that such Covered Person remains liable for any violation of the terms of this
Section 4(a) by such Persons as if they were such Covered Person), (x) on a confidential basis to her, his or its legal counsel
and accountants for the purpose of evaluating the legal and financial ramifications of this Agreement, the transactions contemplated hereby,
the Merger Agreement or the transactions contemplated thereby (provided that such Covered Person remains liable for any violation
of the terms of this Section 4(a) by such Persons as if they were such Covered Person), (y) as required by applicable law,
rule or regulation and (z) in court filings, as reasonably necessary in connection with the enforcement by such Covered Person of his,
her or its rights under this Agreement or any other agreement relating hereto or to such Covered Person’s services to Holdco, Buyer,
the Company and/or their respective Subsidiaries, except for disclosure required by law, rule or regulation. Each Covered Person shall
not, and shall use reasonable best efforts to cause his, her or its Representatives not to, issue any press release, have any communication
with the press (whether or not for attribution) or make any other public statement with respect to this Agreement, the Merger Agreement,
the other Transaction Documents or the transactions contemplated hereby or thereby, without the prior written consent of Buyer.
(b)
Notwithstanding anything in this Agreement (including the confidentiality obligations set forth in Section 4(a)) or
otherwise, it is understood that nothing in this Agreement limits the Covered Person from (i) filing a charge or complaint with the Equal
Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities
and Exchange Commission (“SEC”) or any other federal, state or local government agency or commission (collectively,
“Government Agencies”); (ii) communicating with any Government Agency or otherwise participating in any investigation
or proceeding that may be conducted by any Government Agency; (iii) testifying in a legal, arbitral or Governmental Agency proceeding;
(iv) exercising Covered Person’s rights (if any) under Section 7 of the National Labor Relations Act; or (v) discussing or disclosing
information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that such Covered Person has
reason to believe is unlawful. A Covered Person does not need the prior authorization of Buyer, the Company or any of their respective
Affiliates to make any reports or disclosures, and a Covered Person shall not be required to notify Buyer, the Company or any of their
respective Affiliates that such reports or disclosures have been made. Neither Buyer, the Company nor any of their respective Affiliates
may retaliate against a Covered Person for any of these activities, and nothing
in this Agreement requires a Covered Person
to waive any monetary award or other payment that the Covered Person might become entitled to from the SEC or any other Government Entity
or self-regulatory organization. Pursuant to the Defend Trade Secrets Act of 2016 (which added 18 U.S.C. § 1833(b)), the parties
agree that a Covered Person shall not have criminal or civil liability under any federal or state trade secret law for the disclosure
of a trade secret that (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly,
or to an attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint
or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition and without limiting the preceding
sentence, if a Covered Person files a lawsuit for retaliation by Buyer, the Company or any of their respective Affiliates for reporting
a suspected violation of law, the Covered Person may disclose the trade secret to my attorney and may use the trade secret information
in the court proceeding, if the Covered Person (x) files any document containing the trade secret under seal and (y) do not disclose the
trade secret except pursuant to court order. Nothing in this Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create
liability for disclosures of trade secrets that are expressly allowed by such Section. A Covered Person’s rights as described in
this paragraph are referred to as the “Protected Rights”.
(c)
Non-Competition. In connection with the Covered Person’s sale of Company Common Stock and/or receipt of a portion
of the aggregate Merger Consideration, during the period starting on the date of this Agreement and ending on the five-year anniversary
of the Closing (the “Restricted Period”), each Covered Person shall not directly or indirectly, whether as an individual,
partner, joint venturer, owner, manager, equityholder, employee, officer, director, independent contractor or otherwise, engage in any
activity or business that competes in any material respect with any business, regardless of where such business is located, that develops,
manufactures, distributes or sells lidar technology or lidar based solutions (a “Competitive Activity”); provided,
that the foregoing shall not prohibit any Covered Person from: (i) holding publicly traded securities of any Person engaged in a Competitive
Activity to the extent that such investment does not, directly or indirectly, confer on such Covered Person (together with his, her or
its Affiliates) more than 5% of the voting power of such Person; (ii) making passive investments in a venture capital, private debt or
private equity fund (“Private Fund”); or (iii) if such Covered Person is no longer providing services to Holdco, Buyer,
the Company and/or their respective Subsidiaries, rendering services as an employee, consultant, advisor, partner or member of a venture
capital, private debt or private equity firm, that makes investments in entities that engage in a Competitive Activity (a “Portfolio
Company”) so long as such Covered Person does not serve as an advisor, director, employee, consultant or maintain any other
service relationship with a Portfolio Company.
(d)
Non-Solicitation and No Hire. In connection with the Covered Person’s sale of Company Common Stock and/or receipt
of a portion of the aggregate Merger Consideration, during the Restricted Period, each Covered Person shall not directly or indirectly,
solicit or encourage any of the directors, officers, managers, employees, contractors, consultants or other service providers of the Company
or any of its respective
Affiliates (including, for the avoidance
of doubt, Buyer and its Subsidiaries from the Closing) to cease or curtail its, his or her relationship with such Persons, or hire or
attempt to hire, whether as a director, officer, manager, employee, contractor, consultant or other service provider, any such Person;
provided, however, that the foregoing shall not prohibit (i) the solicitation of any such Person resulting from generalized
searches for employees through the use of bona fide public advertisements in the media or any general recruitment efforts conducted by
such Covered Person or any Affiliate thereof or any recruitment agency, in each case, that are not targeted specifically at such Persons
or (ii) the solicitation or hiring of any such Person who has not been employed by or otherwise provided services to Buyer, the Company
or any of their respective Subsidiaries or Affiliates for at least six (6) months prior to the date of such solicitation or hiring.
(e)
Non-Disparagement. In connection with its, his or her sale of Company Common Stock and/or receipt of a portion of the aggregate
Merger Consideration, during the Restricted Period, each Covered Person shall not, directly or indirectly, (i) interfere with, or attempt
to interfere with, the business the Company or any of its respective Affiliates (including, for the avoidance of doubt, Buyer and its
Subsidiaries from the Closing), or any of their relationships with any current or prospective customers, vendors, suppliers, contractors
or other material business relationships, including by soliciting or diverting (or attempting to solicit or divert) any such Person, or
inducing (or attempting to induce) any such Person to cease doing business, or reduce or otherwise limit its business, with the Company
or any of its respective Affiliates (including, for the avoidance of doubt, Buyer and its Subsidiaries from the Closing) or (ii) make
any negative or disparaging statements or communications regarding the Company or any of its respective Affiliates (including, for the
avoidance of doubt, Buyer and its Subsidiaries from the Closing), in each case, except with respect to the Protected Rights.
(f)
Certain Acknowledgments. Each Covered Person (on its, his or her own behalf) acknowledges that Buyer and Merger Sub would
not be willing to enter into the Merger Agreement or the other Transaction Documents, or consummate the transactions contemplated thereby,
in the absence of this Agreement, and that the covenants contained in this Agreement constitute a material inducement to Buyer and Merger
Sub to enter into, and consummate the transactions contemplated by (including payments of the amounts contemplated by), the Merger Agreement
and the other Transaction Documents. Without limiting the generality of the foregoing, each Covered Person (on its, his or her own behalf
and on behalf of its, his or her Affiliates) acknowledges and agrees that the restrictions contained in this Section 4
are reasonable and necessary to protect the legitimate interests of Buyer, and it is the intention of the parties hereto that if any of
the restrictions or covenants contained in this Section 4 are for any reason held invalid,
illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this
Section 4, and this Section 4 shall
be construed as if such invalid, illegal or unenforceable provision had never been contained herein. It is the further intention of the
parties hereto that if any of the restrictions or covenants contained herein is held to cover a geographic area or to be for a length
of time which is not permitted by applicable Law, or in any way construed to be too broad or to any extent invalid, such provision shall
(to the maximum extent permitted by applicable Law) not be
construed to be null, void and of no effect,
but instead shall be construed and interpreted or reformed to provide for a covenant having the maximum enforceable geographic area, time
period and other provisions (not greater than those contained herein) as shall be valid and enforceable under such applicable Law.
5.
Other Closing Deliverables. Each Covered Person hereby agrees, contemporaneously with the Closing, to deliver to Holdco
a duly executed IRS Form W-9 for such Covered Person. Furthermore, as a condition to the issuance of any Holdco Securities hereunder,
each Covered Person shall, prior to the Closing, deliver to Holdco a customary questionnaire certifying its status as an accredited investor
and any other information reasonably requested by Holdco for such purpose.
6.
Limitation on Holdco Liability. Each of the parties hereto agrees and acknowledges that Holdco has no obligation
by virtue of this Agreement to effect the Closing, and neither Holdco nor any of its Affiliates nor any of their respective directors,
officers, employees or agents shall have any liability whatsoever hereunder, or in connection herewith, for any failure to effect the
Closing (whether or not such failure is (or is deemed to be) in breach of the Merger Agreement, this Agreement or otherwise); provided,
however, that nothing in this Section 6 shall limit, impair, impact or restrict the rights of the Company under the Merger Agreement.
7.
Specific Performance.
(a)
Subject to Section 7(b), (i) each party hereto acknowledges and agrees that the
other parties would be irreparably damaged in the event that any of the terms or provisions of this Agreement are not performed in accordance
with their specific terms or otherwise are breached, (ii) therefore, notwithstanding anything to the contrary set forth in this Agreement,
each party hereto hereby agrees that the other parties shall be entitled to an injunction or injunctions to prevent breaches of any of
the terms or provisions of this Agreement and/or specific performance by any other party, and each party hereby agrees to waive the defense
(and not to interpose as a defense or in opposition) in any such suit that the other parties have an adequate remedy at law, and hereby
agrees to waive any requirement to post any bond in connection with obtaining such relief and (iii) the equitable remedies described in
this Section 7 shall be in addition to, and
not in lieu of, any other remedies at law or in equity that the parties may elect to pursue.
(b)
Notwithstanding anything to the contrary contained in this Agreement, in no event shall any Covered Person or any other Person
have any right whatsoever to cause Buyer or any of its Affiliates to consummate the Closing, and in no event shall any other party hereto
or any other Person be entitled to seek or obtain any injunction or injunctions to compel Buyer or any of its Affiliates to consummate
the Closing, except for the right of the Company to seek specific performance of the obligations of Buyer pursuant to the express terms
of Section 10.08 of the Merger Agreement (but subject to the limitations set forth therein).
8.
Governing Law. This Agreement, and all claims or causes of action (whether at law, in contract or in tort or otherwise)
that may be based upon, arise out of or relate to this
Agreement or the negotiation, execution or performance
hereof, shall be governed by and construed in accordance with the internal laws of the State of Delaware applicable to agreements made
and to be performed entirely within the State of Delaware, without giving effect to any choice or conflict of law provision or rule (whether
of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State
of Delaware. Each party expressly agrees and acknowledges that the State of Delaware has a reasonable relationship to the parties and/or
this Agreement.
9.
Jurisdiction; Waiver of Jury Trial. Each party to this Agreement, by his, her or its execution hereof, hereby irrevocably
(a) agrees and consents to be subject to the exclusive jurisdiction of the United States District Court located in the State of Delaware
(and in the absence of federal jurisdiction, the parties consent to be subject to the exclusive jurisdiction of the Delaware Chancery
Court located in Wilmington, Delaware or, if such court lacks jurisdiction, the other state courts located in Wilmington, Delaware), and
agrees not to object to venue in the courts or to claim that such forum is inconvenient, (b) waives to the extent not prohibited by applicable
Law, and agrees not to assert, by way of motion, as a defense or otherwise, in any such action, suit or proceeding any claim that it is
not subject personally to the jurisdiction of the above-named courts, that his, her or its property is exempt or immune from attachment
or execution, that any such action, suit or proceeding brought in one of the above-named courts should be dismissed on grounds of improper
venue or forum non conveniens, should be transferred or removed to any court other than one of the above-named courts, or should be stayed
by reason of the pendency of some other action, suit or proceeding in any other court other than one of the above-named courts, or that
this Agreement or the subject matter hereof may not be enforced in or by such court and (c) agrees not to commence or prosecute any such
action, suit or proceeding other than before one of the above-named courts nor to make any motion or take any other action seeking or
intending to cause the transfer or removal of any such action, suit or proceeding to any court other than one of the above-named courts
whether on the grounds of lack of personal jurisdiction, improper venue, inconvenient forum or otherwise. Each party hereby irrevocably
(x) consents to service of process in any such action, suit or proceeding in any manner permitted by the laws of the State of Delaware;
(y) agrees that service of process made in accordance with clause (x) will constitute good and valid service of process in any such action,
suit or proceeding; and (z) waives and agrees not to assert (by way of motion, as a defense, or otherwise) in any such action, suit or
proceeding any claim that service of process made in accordance with clause (x) or clause (y) does not constitute good and valid service
of process. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT
OF OR RELATED TO THIS AGREEMENT, THE MERGER AGREEMENT, THE LLC AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.
10.
Termination. This Agreement shall automatically terminate and be of no further force or effect upon any valid termination
of the Merger Agreement.
11.
Counterparts; Entire Agreement; Amendment. This Agreement may be executed in any number of counterparts each of which shall
be an original with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement, together with
the Merger Agreement and any other Transaction Documents to which the parties hereto are party,
constitutes the entire agreement between the parties
hereto with respect to the subject matter hereof and supersedes all other prior agreements and understandings, whether written, oral or
implied, between or among any of the parties with respect to the subject matter hereof and shall not be assigned by operation of law or
otherwise. This Agreement may be amended only by an instrument in writing signed on behalf of each of the parties hereto.
12.
Successors and Assigns. This Agreement shall be binding upon and inure solely to the benefit of each party hereto and his,
her or its successors and permitted assigns; provided that no party may assign, delegate or otherwise transfer any of his, her
or its rights or obligations under this Agreement without the consent of the other party hereto (except that Holdco may assign his, her
or its rights and obligations under this Agreement in whole or in part to one or more of his, her or its Affiliates). Each Covered Person
agrees to be responsible for compliance with this Agreement by any Affiliate of such Covered Person, and any breach of this Agreement
by any such Affiliates shall be deemed a breach by such Covered Person.
13.
Spouses. Each Spouse of a Covered Person (if applicable) hereby represents, warrants and covenants to Holdco that such Spouse
shall not assert or enforce, and does hereby waive, any rights granted under any community property statue with respect to the Subject
Securities that would adversely affect (x) the covenants made by such Covered Person pursuant to this Agreement or (y) the transactions
contemplated by the Merger Agreement and the other Transaction Documents.
[Signature page follows]
| |
Very truly yours, |
| |
|
| |
KOITO
MANUFACTURING CO., LTD. |
| |
|
| |
|
|
|
| |
By: |
/s/ Michiaki Kato
|
| |
|
Name: |
Michiaki Kato
|
| |
|
Title: |
President
and COO
|
| |
PROJECT CAMARO HOLDINGS, LLC |
| |
By: KOITO MANUFACTURING CO., LTD., as its sole member
|
| |
|
|
|
| |
By: |
/s/ Hideharu Konagaya
|
| |
|
Name: |
Hideharu Konagaya
|
| |
|
Title: |
Executive
Vice President
|
[Signature Page to Rollover Agreement]
Accepted and Agreed to:
| COVERED PERSON |
|
SPOUSE (if applicable) |
| |
|
|
| By: |
/s/ Jun Pei |
|
/s/ Yiyan Liu |
| |
Jun Pei |
|
Yiyan Liu |
Total number of shares of Common Stock
beneficially owned by such Covered Person:
_________________
The Committed Rollover Shares: 1,291,810
shares of Common Stock
Address for notices:
[Signature Page to Rollover Agreement]
Accepted and Agreed to:
| COVERED PERSON |
|
SPOUSE (if applicable) |
| |
|
|
| By: |
/s/ Mark McCord |
|
/s/ Libby McCord |
| |
Mark McCord |
|
Libby McCord |
Total number of shares of Common Stock
beneficially owned by such Covered Person:
_________________
The Committed Rollover Shares: 515,886
shares of Common Stock
Address for notices:
[Signature Page to Rollover Agreement]
Accepted and Agreed to:
| COVERED PERSON |
|
SPOUSE (if applicable) |
| |
|
|
| By: |
/s/ Yupeng Cui |
|
|
| |
Yupeng Cui |
|
|
Total number of shares of Common Stock
beneficially owned by such Covered Person:
_________________
The Committed Rollover Shares: 476,549
shares of Common Stock
Address for notices:
[Signature Page to Rollover Agreement]
ANNEX
I
Form
of Joinder Agreement
This Joinder Agreement
(this “Joinder Agreement”) is made as of the date written below by the undersigned (the “Joining Party”)
in accordance with the Rollover Agreement, dated as of July 29, 2024, by and among Holdco and certain other persons, as the same may
be amended from time to time (the “Rollover Agreement”). Capitalized terms used, but not defined, herein shall have
the meaning ascribed to such terms in the Rollover Agreement.
The Joining Party
hereby acknowledges, agrees and confirms that, by its execution of this Joinder Agreement, the Joining Party shall be deemed to be a
party to and a “Covered Person” under the Rollover Agreement as of the date hereof and shall have all of the rights and obligations
of a Covered Person as if it had executed the Rollover Agreement. The Joining Party hereby ratifies, as of the date hereof, and agrees
to be bound by, all of the terms, provisions and conditions applicable to a Covered Person contained in the Rollover Agreement.
IN WITNESS WHEREOF,
the undersigned has executed this Joinder Agreement as of the date written below.
Date: __________ ___, 20___
| JOINING PARTY |
|
SPOUSE (if applicable) |
| |
|
|
| By: |
|
|
|
| |
[•] |
|
[•] |
Total number of shares
of Common Stock beneficially owned by such Covered Person: _________________
The Committed Rollover
Shares: [●] shares of Common Stock
Annex I – 1
AGREED ON THIS ___ day of ____, 20__:
KOITO MANUFACTURING CO., LTD.
PROJECT CAMARO HOLDINGS, LLC
Annex
I – 2
ANNEX
II
LLC
Agreement
Annex
II – 1
ANNEX
III
Representations
and Warranties of Covered Persons (and, if applicable, Spouses)
Each Covered Person
(and, if applicable, his or her Spouse) represents and warrants, severally and not jointly, to Holdco as of the date hereof (or, in the
case of any Covered Person becomes a party hereto by delivering a Joinder Agreement as contemplated by Section 1(c), as of
the date of such Joinder Agreement) and as of the Closing and as to itself, himself or herself only (and, if applicable, his or her Spouse),
as follows:
(a)
Such Covered Person is knowledgeable, sophisticated and experienced in business and financial matters, is experienced in evaluating
investments in companies such as Holdco and has reviewed the definition of “accredited investor” set forth in Rule 501 of
Regulation D under the Securities Act of 1933, as amended (the “Securities Act”) and is an “accredited investor”
as defined therein.
(b)
The Holdco Securities to be acquired pursuant to this Agreement are being acquired for such Covered Person’s own account,
for investment purposes, and without a view to any distribution thereof.
(c)
Such Covered Person (i) has been afforded access to information about Holdco and the financial condition, results of operations,
business, property and management of Holdco sufficient to enable it, him or her to evaluate its, his or her investment in the Holdco
Securities, (ii) understands that no financial statements are currently available for Holdco, and (iii) has reviewed the financial statements
of the Company (which, as of the Closing, will be a direct or indirect wholly owned Subsidiary of Holdco) and such other documents as
such Covered Person has reasonably deemed advisable. Such Covered Person and its, his or her advisors, if any, have been afforded the
opportunity to ask questions of Holdco. Such Covered Person acknowledges that such Covered Person has been provided access to relevant
documents regarding Holdco and its Subsidiaries, including: (i) the financial statements of the Company and (ii) the principal terms
of the proposed LLC Agreement, a copy of which principal terms is attached hereto as Annex II. Such Covered Person has sought
such accounting, legal and tax advice as he or she has considered necessary to make an informed investment decision with respect to its,
his or her acquisition of the Holdco Securities.
(d)
Such Covered Person understands that its, his or her investment in the Holdco Securities involves a high degree of risk and such
Holdco Securities are, therefore, a speculative investment. Such Covered Person is able to bear the economic risk of its, his or her
investment in the Holdco Securities for an indefinite period of time, and is presently able to afford the complete loss of such investment.
(e)
Such Covered Person acknowledges that it, he or she has conducted to its, his or her satisfaction an independent investigation
of the financial condition, results of operations, assets, liabilities, properties, taxes and projected operations of Holdco and the
Company and, in making the determination to acquire the Holdco Securities, has relied solely on the results of its, his or her own independent
investigation, and is not relying
(for purposes
of making any investment decision or otherwise) upon any advice, counsel or representations (whether written or oral) of Holdco or any
of its officers, employees, agents, advisors or Affiliates, other than the representations and warranties of Holdco set forth in Annex
IV. Such Covered Person further acknowledges and agrees that Holdco has made no representations or warranties either express or implied
as to the accuracy or completeness of any information regarding Holdco or the Company furnished or made available to such Covered Person
and its, his or her representatives, and such Covered Person shall have no claim with respect to any information, documents or materials
furnished by or on behalf of Holdco to such Covered Person.
(f)
Such Covered Person is not purchasing the Holdco Securities as a result of any advertisement, article, notice or other communication
regarding the Holdco Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented
at any seminar or any other general advertisement or solicitation, and the offer to purchase the Holdco Securities was directly communicated
to such Covered Person by Holdco.
(g)
Such Covered Person understands that the Holdco Securities that it, he or she is purchasing are “restricted securities”
as defined in Rule 144(a)(3) under the Securities Act inasmuch as they are being acquired from Holdco in a transaction not involving
a public offering and that under such applicable Laws the Holdco Securities may not be offered or sold except in a transaction registered
under the Securities Act on an effective registration statement or in a transaction effected pursuant to an exemption from such registration.
Such Covered Person understands that no Governmental Authority has passed on or made any recommendation or endorsement of the Holdco
Securities or the fairness or suitability of the investment in the Holdco Securities, nor has any Governmental Authority passed upon
or endorsed the merits of the offering of the Holdco Securities.
(h)
Such Covered Person, in making its, his or her decision to purchase the Holdco Securities, has made its, his or her own investment
decision regarding its, his or her purchase of the Holdco Securities, (including the income tax consequences of purchasing, owning or
disposing of the Holdco Securities in light of such Covered Person’s particular situation and tax residence(s) as well as any consequences
arising under the applicable Laws of any taxing jurisdiction).
(i)
(i) If such Covered Person is not a natural person, such Covered Person is duly organized, validly existing and in good standing
(where applicable) under the laws of the jurisdiction in which it is incorporated, organized or constituted, (ii) such Covered Person
has the legal capacity and has all requisite power and authority to execute and deliver this Agreement and to perform its, his or her
obligations hereunder, (iii) this Agreement has been duly executed and delivered by such Covered Person and, assuming that this
Agreement has been duly authorized, executed and delivered by Holdco and Buyer, this Agreement constitutes a valid and binding obligation
of such Covered Person, enforceable against such Covered Person in accordance with its terms (except as enforceability may be limited
by bankruptcy laws, other similar laws affecting creditors’ rights and general principles of equity affecting the availability
of specific performance
and other
equitable remedies), (iv) if such Covered Person is married and such Covered Person’s Subject Securities (as defined below) constitute
community property under applicable Law, such Covered Person’s spouse (the “Spouse”) has the legal capacity
and has all requisite power and authority to execute and deliver this Agreement and to perform its, his or her obligations hereunder,
this Agreement has been duly executed and delivered by such Spouse and, assuming that this Agreement has been duly authorized, executed
and delivered by Holdco, this Agreement constitutes a valid and binding obligation of such Spouse, enforceable against such Spouse in
accordance with its terms (except as enforceability may be limited by bankruptcy laws, other similar laws affecting creditors’
rights and general principles of equity affecting the availability of specific performance and other equitable remedies), (v) if this
Agreement is being executed in a representative or fiduciary capacity, the Person signing this Agreement has full power and authority
to enter into and perform this Agreement on behalf of such Covered Person or Spouse, and (vi) the LLC Agreement will be duly executed
and delivered by such Covered Person (and, if applicable, his or her Spouse) at or prior to the Closing, and upon execution and delivery
will constitute a valid and binding agreement of such Covered Person (and, if applicable, his or her Spouse), assuming that the LLC Agreement
has been duly authorized, executed and delivered by the other parties thereto, and (vii) the execution, delivery and performance by such
Covered Person (and, if applicable, his or her Spouse) of this Agreement, and the LLC Agreement, requires no action by or in respect
of, or filing with, any Governmental Authority.
(j)
Such Covered Person is the record and beneficial owner (as defined in Rule 13d-3 under the Securities Act) of, and has good title
to, the number of share of Common Stock indicated on such Covered Person’s signature page hereto (collectively, the “Subject
Securities”), free and clear of all Liens and free of any other limitation or restriction (including any restriction on the
right to vote, sell or otherwise dispose of such Subject Securities), other than generally applicable transfer restrictions under the
Securities Act, this Agreement or the Voting Support Agreements (if applicable to such Covered Person), and such Subject Securities are
the only shares of Common Stock of the Company or any of its Subsidiaries owned, directly or indirectly, of record or beneficially, by
such Covered Person or any of its Affiliates. None of such Covered Person’s Subject Securities are subject to any voting trusts,
stockholder agreements, proxies, or other agreements or understandings in effect with respect to the voting or transfer of such shares,
except as provided hereunder or in the Voting Support Agreements (if applicable to such Covered Person).
(k)
Such Covered Person has received and reviewed a copy of this Agreement and the Merger Agreement, has had an opportunity to obtain
the advice of counsel prior to executing this Agreement and fully understands and accepts all of the provisions hereof and of the Merger
Agreement, including that the consummation of the Merger is subject to the conditions set forth in the Merger Agreement, and so there
can be no assurance that the Merger will be consummated.
(l)
The execution and delivery of this Agreement by such Covered Person (and, if applicable, his or her Spouse) does not, and the
performance by such Covered Person (and, if applicable, his or her Spouse) of its, his or her obligations hereunder will
not, (i)
result in any violation of any applicable Law, (ii) if such Covered Person is not an individual, violate any provision of the Organizational
Documents of such Covered Person, (iii) require any consent that has not been given or other action (including notice or payment) that
has not been taken by any Person (including under any provision of any contract binding upon such Covered Person (and, if applicable,
his or her Spouse) or such Covered Person’s Subject Securities) or (iv) result in the imposition of any Lien upon such Covered
Person’s Subject Securities, other than restrictions imposed under this Agreement or the LLC Agreement.
(m)
There is no Legal Proceeding pending against, or to the knowledge of such Covered Person
(or, if applicable, his or her Spouse), threatened against such Covered Person (and,
if applicable, his or her Spouse) or any of its Affiliates, by or before (or that would be by or
before) any Governmental Authority or arbitrator that, if determined or resolved adversely in accordance with the plaintiff’s demands,
would reasonably be expected, individually or in the aggregate, to prevent, enjoin or materially
delay the consummation of the transactions contemplated by, or the performance by the Company or the Covered Person of its obligations
under, the Merger Agreement or any of the other Transaction Documents. None of such
Covered Person or any of its Affiliates is subject to any judgment, decree, injunction, ruling, award, subpoena, determination, verdict
or order of any Governmental Authority or arbitrator that would reasonably be expected, individually or in the aggregate, to prevent,
enjoin or materially delay the consummation of the transactions contemplated by, or the performance by the Company or such Covered Person
of its obligations under, the Merger Agreement or any of the other Transaction Documents.
(n)
Except as provided in Section 4.26 of the Merger Agreement, no investment banker, broker, finder or other intermediary is entitled
to a fee or commission from Buyer, Holdco, the Company or any of their respective Affiliates in respect of the Merger Agreement, this
Agreement or any of the respective transactions contemplated thereby and hereby based upon any arrangement or agreement made by or, to
the knowledge of the Covered Person, on behalf of, such Covered Person.
(o)
Such Covered Person understands that Holdco, as the issuer of the Holdco Securities, is relying in part upon the representations
and agreements contained in this Annex III for the purpose of determining whether the offer, sale and issuance of the Holdco Securities
meets the requirements for an applicable exemption from registration under the Securities Act.
(p)
Except for the representations and warranties of such Covered Person contained in this Agreement, such Covered Person makes no
other representation or warranty express or implied in connection with, arising out of or relating to, the transactions contemplated
by this Agreement, and Holdco hereby disclaims, and Holdco may not rely on, any such other representation or warranty, notwithstanding
the delivery or disclosure to Holdco or any of its Affiliates or any other Person of any documentation or other information by such Covered
Person or any of his, her or its Affiliates or any other Person with respect to any of such matters. Such Covered Person hereby acknowledges
and agrees to the provisions in clause (e) of Annex IV.
ANNEX
IV
Representations
and Warranties of Holdco
Holdco represents
and warrants to each Covered Person as of the date hereof and as of the Closing, as follows:
(a)
Holdco was formed solely for the purpose of completing the transactions contemplated by the Merger Agreement and the other Transaction
Documents to which it is a party and for holding, directly or indirectly, the Company Common Stock and other equity securities to be
acquired pursuant thereunder. Except for (i) customary obligations or liabilities incurred in connection with its organization, and (ii)
obligations or liabilities incurred in connection with the Merger Agreement and the other Transaction Documents and the transactions
contemplated thereby, Holdco has not incurred any material obligations or liabilities or engaged in any material business activities.
(b)
At the Closing, the Holdco Securities to be issued hereunder will have been duly and validly authorized and, when issued, sold
and delivered in accordance with the terms hereof for the consideration expressed herein, and will be duly and validly issued Holdco
Securities free and clear of all Liens, other than generally applicable transfer restrictions under the Securities Act. There are no
statutory or contractual preemptive rights or rights of refusal with respect to the issuance of the Holdco Securities under this Agreement.
(c)
Holdco has the organizational power and authority to enter into this Agreement and the LLC Agreement and to perform its obligations
hereunder and thereunder. The execution, delivery and performance of this Agreement by Holdco have been duly authorized by all necessary
action on the part of Holdco. This Agreement has been duly executed and delivered by Holdco and constitutes a valid and binding agreement
of Holdco. The LLC Agreement will be duly executed and delivered by Holdco at or prior to the Closing, and upon execution and delivery
will constitute a valid and binding agreement of Holdco. The execution, delivery and performance by Holdco of this Agreement and the
LLC Agreement requires no action by or in respect of, or filing with, any Governmental Authority.
(d)
None of the execution and delivery by Holdco of this Agreement, the consummation by Holdco of the transactions contemplated hereby
(including the issuance, sale and delivery of the Holdco Securities hereunder), or compliance by Holdco with any of the provisions hereof
does or will conflict with, or result in any violation of or default (with or without notice or lapse of time, or both) under (i) any
order of any Governmental Authority applicable to Holdco or by which any of the properties or assets of Holdco are bound; (ii) any applicable
Law; (iii) any provision of Holdco’s Organizational Documents or (iv) any material contracts or agreements of Holdco.
(e)
Except for the representations and warranties of Holdco contained in this Agreement, Holdco makes no other representation or warranty
express or implied in connection with, arising out of or relating to, the transactions contemplated by this
Agreement,
and each Covered Person hereby disclaims, and each Covered Person may not rely on, any such other representation or warranty, notwithstanding
the delivery or disclosure to such Covered Person or any of its Affiliates or any other Person of any documentation or other information
by Holdco or any of its Affiliates or any other Person with respect to any of such matters. Holdco hereby acknowledges and agrees to
the provisions in clause (p) of Annex III.
Cepton (NASDAQ:CPTN)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Cepton (NASDAQ:CPTN)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
